Dabur has announced its anticipation of a modest revenue uptick for the October to December quarter, with expectations set for a low single-digit increase in income and a steady operating profit.
The company, known for its ayurvedic offerings, indicated that its health care business might experience stagnant growth, as reported by Reuters. Meanwhile, its personal care and home care segments are projected to see sales growth in the mid to high single-digit tiers.
Challenges faced by India’s leading FMCG firms are linked to diminishing demand amid significant deflation and rising raw material expenses, as highlighted by Reuters. Dabur shared with Reuters that it has observed a resurgence in demand within rural areas, an effect being counterbalanced by strategic cost reductions and adjustments in pricing to manage heightened input expenses.